Stereochemical Identity of a Single Fluorosugar Enables Noninvasive Dual-Biomarker Fingerprinting of Cancer
Journal of the American Chemical Society · 17.11.2026
DOI: 10.1021/jacs.6c16535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 17.11.2026. Verfasst von Dan Cohen und 17 weiteren Autor:innen. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Israel Science Foundation, German-Israeli Foundation for Scientific Research and Development.
Abstract (Originalsprache)
Clinical molecular imaging of cancer largely relies on single biomarker-attributable readouts. Through an efficient trapping mechanism, 2-[18F]FDG robustly links PET readouts to the Warburg effect, illuminating only a single metabolic axis within the multichannel biochemical network of cancer. The versatile chemical space of synthetic fluorosugars, however, may offer an attractive framework for broadening the repertoire of metabolic markers accessible to noninvasive imaging. Here, we report Fluorine Metabolic Imaging (FMI), a molecular MRI strategy for simultaneous in vivo mapping of two metabolic biomarkers using a single probe. FMI exploits the altered biochemistry of 3-fluoro-3-deoxy-d-galactose (3FDGal), which undergoes orthogonal intracellular redox transformations mediated by ALDH1A1 and AKR1B1, each yielding a stably trapped fluorine-labeled metabolite with a characteristic 19F-NMR peak. Concurrently mapped by 19F-MRI, these two enzyme-attributable readouts enable noninvasive spatially resolved dual-biomarker visualization. We establish the trapping mechanism of 3FDGal and its enzymatic basis, demonstrating that 3FDGal-initiated fingerprints reflect dual-biomarker variations across different cancer cells. In vivo, FMI distinguishes tumors with contrasting metabolic phenotypes, herein demonstrated in human xenografts not detectable by the canonical 2-[18F]FDG-PET approach. Establishing this proof-of-concept platform for noninvasive multilayered tumor subtyping, FMI with fluorosugars extends metabolic imaging beyond the Warburg scheme into unexplored dimensions of cancer diagnostics.
Förderung
- European Commission
- Israel Science Foundation
- German-Israeli Foundation for Scientific Research and Development
- Clore Israel Foundation
- Clore Institute for High-Field Magnetic Resonance Imaging and Spectroscopy
Zitieren
APA
Cohen, D., Saad, L., Subramani, B., Kutchinsky, S., Fisler, M., Hayun, R. Z., Avram, L., Diskin-Posner, Y., Harris, T., Feler, A., Brandis, A., Carvalho, S., Kellner, C., Graf, D., Goulet, C. S., Shuhendler, A. J., Allouche-Arnon, H., & Bar-Shir, A. (2026). Stereochemical Identity of a Single Fluorosugar Enables Noninvasive Dual-Biomarker Fingerprinting of Cancer. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.6c16535
Vancouver
Cohen D, Saad L, Subramani B, Kutchinsky S, Fisler M, Hayun RZ, et al. Stereochemical Identity of a Single Fluorosugar Enables Noninvasive Dual-Biomarker Fingerprinting of Cancer. Journal of the American Chemical Society. 2026. doi:10.1021/jacs.6c16535
BibTeX
@article{Cohen2026,
author = {Cohen, Dan and Saad, Libi and Subramani, Balamurugan and Kutchinsky, Shira and Fisler, Michal and Hayun, Raz Z. and Avram, Liat and Diskin-Posner, Yael and Harris, Talia and Feler, Ariel and Brandis, Alexander and Carvalho, Silvia and Kellner, Claudia and Graf, Dominic and Goulet, Clara S. and Shuhendler, Adam J. and Allouche-Arnon, Hyla and Bar-Shir, Amnon},
title = {Stereochemical Identity of a Single Fluorosugar Enables Noninvasive Dual-Biomarker Fingerprinting of Cancer},
journal = {Journal of the American Chemical Society},
year = {2026},
doi = {10.1021/jacs.6c16535}
}
EUVIMED